Trump Moves to Oust FDA Commissioner Over Flavored Vape Approvals
President Donald Trump has reportedly signed off on a plan to fire Food and Drug Administration Commissioner Marty Makary. This looming dismissal stems from severe clashes over Makary’s reluctance to quickly approve new fruit-flavored vapes, highlighting Trump’s push to fulfill his 2024 campaign promise to “save flavored vaping.”
The conflict reached a boiling point after Makary issued a February memo effectively blocking the authorization of blueberry and mango vape flavors manufactured by Los Angeles-based Glas Inc. The FDA commissioner argued he needed more time to determine if the products and their age-verification systems adequately protected public health while preventing teen access.
Following direct pressure from Trump, the FDA reversed course this week, issuing its first-ever authorization of fruit-flavored electronic cigarettes intended for adult smokers. The agency reiterated that this is not an endorsement, but a harm-reduction tool for adults trying to quit traditional cigarettes.
To address the teen vaping epidemic—which has currently dropped to a 10-year low of 6% among students—Glas implemented a rigorous digital age-verification system. The technology requires:
- Government ID verification via a smartphone application.
- Biometric data collection (facial recognition) to confirm user identity.
- An active Bluetooth connection; if the user’s phone dies, the vape ceases to function.
Despite these safeguards, career scientists and Makary raised legitimate efficacy questions. There are significant concerns that older, lower-income adult smokers will not adopt the complex technology. The connected pod systems cost between $40 and $150, with refill pods priced at $11.99, potentially deterring users from switching away from traditional cigarettes.
The Wall Street Journal reported that the FDA’s sudden policy reversal was driven by Trump’s desire to cater to his young voter base and vaping industry backers. White House spokesman Kush Desai defended the administration’s direction, stating they are making “evidence-based decisions that rectify the Biden administration’s missteps.”
Amidst reports of his impending termination, Makary defended his tenure during a recent CNBC interview. While avoiding direct mention of the vaping disputes, he stated, “We have not done corrupt sweetheart deals. What we have done is follow the science.”
- Read more: FDA Deploys AI and Slashes PMTA Review Times for Tobacco Products
- Reference: Trump ‘signed off on plan’ to fire FDA commissioner who slow-walked flavored vapes









